How to treat liver fibrosis

Liver fibrosis is usually caused by factors such as viral hepatitis, alcoholic liver disease, non-alcoholic fatty liver disease, autoimmune liver disease, and bile stasis. It can be treated through medication, etiological control, lifestyle adjustments, regular monitoring, surgical treatment, self-management, and other methods.

1. Drug treatment: Anti fibrotic drugs such as Fuzheng Huayu Capsules, Compound Glycyrrhizin Tablets, etc. Fuzheng Huayu Capsules are representative drugs for anti fibrotic treatment. Its ingredients include Danshen, fermented cordyceps powder, peach kernel, etc. Through the synergistic effects of Danshen promoting blood circulation and removing blood stasis, cordyceps powder regulating immunity, and peach kernel anti-inflammatory, it inhibits excessive activation of hepatic stellate cells and reduces abnormal deposition of extracellular matrix such as collagen; At the same time, it enhances the activity of collagenase, promotes the degradation and absorption of fibrous tissue, and improves liver microcirculation, blocking the process of liver fibrosis through the dual pathways of inhibiting generation and promoting degradation, effectively delaying the development of cirrhosis.

2. Etiological control: Patients with alcoholic liver disease should strictly abstain from alcohol, and patients with viral hepatitis should receive standardized antiviral treatment. Patients with non-alcoholic fatty liver disease need to improve metabolic abnormalities through measures such as weight loss and controlling blood sugar and lipid levels. Fibrosis may continue to progress when the cause is not controlled.

3. Lifestyle adjustment: Consume 60-80 grams of high-quality protein daily, and prioritize fish and soy products. Limit high-fat and high sugar diet, with no more than 5 grams of salt per day. Engage in 150 minutes of moderate intensity aerobic exercise per week, such as brisk walking and swimming, to avoid exacerbating liver burden with vigorous exercise.

4. Regular monitoring: Re check liver elasticity testing and serum fibrosis markers every 3-6 months. High risk individuals with cirrhosis need to undergo gastroscopy every 6-12 months to assess the risk of esophageal varices. When monitoring data is abnormal, the treatment plan should be adjusted in a timely manner.

5. Surgical treatment: Patients with end-stage liver disease may consider liver transplantation, and MELD scores need to be evaluated before surgery. Patients with portal hypertension may require jugular intrahepatic portosystemic shunt to control bleeding. Surgical decision-making should be based on multidisciplinary consultation opinions.

6. Self management: Patients with liver fibrosis should establish a regular schedule, ensure 7-8 hours of sleep per day, and avoid staying up late to increase the burden on the liver. To maintain emotional stability, anxiety can be alleviated through mindfulness meditation, deep breathing, and other methods. Suggest joining a mutual aid organization for liver disease patients to gain psychological support and disease management experience, and enhance treatment confidence. The treatment of liver fibrosis requires joint efforts from doctors and patients. Through precise treatment and scientific management, most patients can effectively control the progression of the disease and improve their quality of life. Patients should actively cooperate with the doctor's treatment recommendations, undergo regular check ups, adjust their plans in a timely manner, and pay attention to self-management, starting from details to safeguard liver health.